New York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, Takeda The dynamics of the inflammatory bowel disease market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies.

美国纽约，2024年5月2日（环球通讯社）--炎症性肠病市场预计到2032年将出现显着增长，DelveInsight预测开发治疗的关键公司-Arena Pharmaceuticals，Pfizer，Abivax，Janssen，Celgene，Eli Lilly and Company，Merck Sharp＆Dohme LLC，Takeda由于诊断方法的改进，对疾病的认识提高，全球医疗保健支出的增加以及新兴疗法的预期推出，预计炎症性肠病市场的动态将在未来几年发生变化。

DelveInsight’s Inflammatory Bowel Disease Market Insights report includes a comprehensive understanding of current treatment practices, inflammatory bowel disease emerging drugs, market share of individual therapies, and current and forecasted inflammatory bowel disease market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

DelveInsight的炎症性肠病市场洞察报告包括对当前治疗实践，炎症性肠病新兴药物，个体疗法市场份额以及2019年至2032年当前和预测的炎症性肠病市场规模的全面了解，细分为7MM[美国，欧盟4国（意大利，西班牙，法国和德国），英国和日本]。

Key Takeaways from the Inflammatory Bowel Disease Market Report According to DelveInsight’s analysis, the market size for inflammatory bowel disease is expected to grow with a significant CAGR by 2032.According to DelveInsight’s analysis in 2023, the total diagnosed prevalent cases of ulcerative colitis and Crohn’s disease accounted for nearly 5 million in the 7MM.  Prominent companies working in the domain of inflammatory bowel disease, including Arena Pharmaceuticals, Pfizer, Abivax, Janssen (Johnson and Johnson), Celgene (Bristol Myers Squibb), Morphic Therapeutic, Inc., Direct Biologics, LLC, Eli Lilly and Company, Merck Sharp & Dohme LLC, Applied Molecular Transport, Genentech, Inc., Rise Therapeutics LLC, Jiangsu Yahong Meditech Co., Ltd aka Asieris, Takeda, Ventyx Biosciences, Inc, Hoffm.

炎症性肠病市场报告的主要收获根据DelveInsight的分析，到2032年，炎症性肠病的市场规模预计将以显着的复合年增长率增长。根据DelveInsight在2023年的分析，溃疡性结肠炎和克罗恩病的总诊断流行病例在7MM中占近500万。在炎症性肠病领域工作的知名公司，包括Arena Pharmaceuticals，Pfizer，Abivax，Janssen（Johnson and Johnson），Celgene（Bristol-Myers Squibb），Morphic Therapeutic，Inc.，Direct Biologics，LLC，Eli Lilly and Company，Merck Sharp＆Dohme LLC，Applied Molecular Transport，Genentech，Inc.，Rise Therapeutics LLC，Jiangsu Yahong Meditech Co.，Ltd aka Asieris，Takeda，Ventyx Biosciences。